S

Surface Oncology Inc
F:QSOA

Watchlist Manager
Surface Oncology Inc
F:QSOA
Watchlist
Price: 0.994 EUR Market Closed
Market Cap: 60.4m EUR

Operating Margin
Surface Oncology Inc

0%
Current
-280%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-86.2m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Surface Oncology Inc
Glance View

Market Cap
60.4m EUR
Industry
Biotechnology

Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company. The company is headquartered in Cambridge, Massachusetts and currently employs 67 full-time employees. The company went IPO on 2018-04-19. The firm is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable an immunologic response and enhance outcomes for patients with cancer. The Company’s pipeline includes two wholly-owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells through targeting CCR8 (SRF114). In addition, the Company has two partnerships with pharmaceutical companies, including a collaboration with Novartis targeting CD73 (NZV930; Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (GSK4381562). Its novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies.

QSOA Intrinsic Value
Not Available
S
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-86.2m
/
Revenue
0
What is the Operating Margin of Surface Oncology Inc?

Based on Surface Oncology Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top